To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our Clinical Trials Program.
Our Supportive Oncology Multidisciplinary Team works with each of our multidisciplinary teams to provide patients expert support for:
Our goal is to improve the quality of life for our cancer patients and their families. These services are available from the time of diagnosis throughout all phases of treatment and care.
The Supportive Care team prides itself on providing a passionate, caring and respectful team-based approach to respond to our patients' physical and emotional needs.
To learn more about supportive oncology at Karmanos, please talk to your Karmanos health care provider.
Kevin Moore
Karmanos Cancer Institute
Andrea Schroeder
Paris Jones
The Barbara Ann Karmanos Cancer Institute has been awarded $459,010 for continued research in treating cancers with radiofrequency electromagnetic...
A Barbara Ann Karmanos Cancer Institute and Wayne State University research team has received a $49,500 grant to research a rare cancer. The grant...
Telegram News Craig Cole, M.D. , malignant hematologist and member of the Hematology Oncology and Multiple Myeloma and Amyloidos...